
Avicenna Days (AAD) 2022
15/02/2022 - 16/02/2022
Free online event,
The Avicenna Alliance
is a global non-profit organization, created in 2016, advocating for the regulation and deployment of in silico methods (i.e. computational modeling and simulation (CM&S)) for healthcare.
The 2022 Avicenna Days will update the entire healthcare community on recent progress and achievements related to the adoption and deployment of in silico methods. We will review the plans to make digital evidences and in silico methods a reality in academic and industrial research, for both regulatory and clinical applications.
Who should attend?
- Any academic or industry researcher and leader involved in medical and pharmaceutical innovation,
- Any Scientists and regulatory affairs professionals interested in digital evidence,
- Clinicians and medical staff intrigued to understand how this technology will help them in their daily activities.
What will you learn?
1.Recent advances supporting in silico methods for research, regulatory and clinical activities, on the medical device, bio/pharma and treatment fields.
2.Academic, industry and regulatory leaders’ visions and timelines for larger scale adoption of in silico medicine.
3.Ask questions, express concerns, debate with experts and peers about important, immediate next steps to combine health care innovation and better patient safety.
Take a look at our Programme and Register today.
Avicenna Days 2022 Programme
Tuesday 15 February 2022
Time: 14.00 – 18:30 CET / 13.00 - 17.30 BST / 18.30 - 23.00 IST / 8.00 - 12.30 EST / 7.00 - 11.30 CST
14:00 - 14:05 Welcome
Roberta Maggi, Office Manager, Avicenna Alliance
14:05 - 14:20 Introduction to Avicenna Alliance
Thierry Marchal, Secretary General, Avicenna Alliance
14:20 - 15:00 The Vision
· Creating a Modeling-Based Culture, Randy Schiestl, Boston Scientific
· Big data, AI and in silico trials based on multiscale modelling and simulation, Blanca Rodriguez, University of Oxford
· Role of Modeling and Simulation in Drug Development and Regulatory Decision-Making, Raj Madabushi, FDA
· Modeling and Simulation at the FDA, Pras Pathmanathan, FDA
15:00 - 15:40 The Achievements
· C4Bio - Community Challenge towards Consensus on the Characterization of Biological Tissue, Nele Famaey, KU Leuven, Chair of Tissue Characterization Task Force
· Engaging with Notified Bodies and other European Stakeholders, Simon Sonntag, Virtonomy, Chair of Notified Bodies Task Force
· Towards Global Harmonization - A Framework that Makes the Game Work, Marc Horner, Ansys, Chair of Global Harmonization Task Force
15:40 - 15:55 BREAK
15:55 - 17:25 From a Technology Dream to a Regulatory Routine: an Ongoing, Successful Journey
· Sharing the Progress on In silico with the world,Mark Palmer, Medtronic, Leader of the International Affairs Working Group and the International Affairs team;
· Adoption of in silico methods for European Regulatory Activities, Emmanuelle Voisin, VCLS, Leader of the Policy Development Working Group and the Policy Development team;
· Avenues for funding and coordinating in silico Research, Liesbet Geris, VPHi, Leader of the Research & Technology Working Group and the Research and Technology team.
17:25 - 18:15 Round Table
The Avicenna Alliance Board will answer your questions and openly discuss key obstacles, opportunities, progress and achievements in front of us.
18:15 - 18:30 Wrap up
Thierry Marchal, Secretary General, Avicenna Alliance
Wednesday 16° February 2022
Time: 14.00 – 17:30 CET / 13.00 - 16.30 BST / 18.30 - 22.00 IST / 8.00 - 11.30 EST / 7.00 - 10.30 CST
14:00 - 14:05 Welcome & Introduction
Thierry Marchal, Secretary General, Avicenna Alliance
14:05 - 15:05 Regulatory Affairs Forum
In Silico in Practice: the view of Developers and Regulators
Speakers:
· Alejandro Frangi, University of Leeds, Chair of the UK Insilico Regulatory Task Force
· Francesco Pappalardo, University of Catania, Chair of the Pharmaceutical Strategy Task Force
· Michael Kipping, Innovate UK
Moderator:
Thierry Marchal, Ansys, Secretary General of the Avicenne Alliance
15:05 - 16:05 Regulatory Affairs Forum
Harmonization & Standardization: Where do we stand?
Speakers:
· Klaus Zeier, DIN
· Luca Emili, InsilicoTrials, Chair of the Good Simulation Practice Task Force
· Walter Schmidt, Stryker
· Angel Guzman Rodriguez, ASME
Moderator:
Marc Horner, Ansys, Chair of the Global Harmonization Task Force
16:05 - 16:15 BREAK
16:15 - 17:15 Regulatory Affairs Forum
Raising Awareness: involving non-engineering communities
Speakers:
· Claudio Capelli, GOSH, Chair of the Clinical Community Outreach Task Force
· Cyrille Thinnes, NUI Galway, Chair of the Public & Patient Involvement Task Force
· Michael Kipping, Innovate UK
· Steven Levine, Dassault Systèmes, Chair of the Public & Patient Involvement Task Force
Moderator:
Cécile Rousseau, VCLS, Key member of the Avicenna Alliance
17:15 - 17:30 Wrap up
Thierry Marchal, Secretary General, Avicenna Alliance
Register today!
Speakers

Thierry Marchal
Avicenna Alliance President and Secretary General
Program Director for Healthcare Solution, ANSYS, Inc.
SEND E-MAIL
Roberta Maggi
Avicenna Alliance Office Manager
Avicenna Alliance
SEND E-MAIL +39.351.8890319
Mathieu Rimaud
Avicenna Alliance Treasurer
CEO, TwInsight
SEND E-MAIL
Cécile Rousseau
In Silico Application Working Group Leader
Senior Director, Nonclinical & Early Clinical Development, VCLS
SEND E-MAIL
Emmanuelle Voisin
In Silico Application Working Group Leader
Founder & CEO, Voisin Consulting Life Sciences (VCLS)
SEND E-MAIL
Liesbet Geris
Research & Technology Working Group Leader
Executive Director, VPH Institute
SEND E-MAIL
Gordon Johnston
Co-Chair of the Artificial Intelligence (AI) Task Force
Digital Health & Innovation at Johnson & Johnson

Marc Horner
Leader of the International Affairs WG & Chair of the Global Harmonization TF
Distinguished Engineer, Ansys

Luca Emili
Co-Chair of the Good Simulation Practice (GSP) Task Force
CEO, InSilicoTrials Technologies

Simon Sonntag
Co-chair of the Notified Bodies (NB) Task Force
CEO and Co-Founder, Virtonomy.

Cyrille Thinnes
Co-chair of the Public & Patient Involvement (PPI) Task Force
Researcher, National University of Ireland, Galway NUI Galway

Steven Levine
Co-chair of the Public & Patient Involvement (PPI) Task Force
Director of Virtual Human Modeling, Dassault Systèmes

Nele Famaey
Co-chair of the Tissue Characterization Task Force
Soft Tissue Biomechanics Professor, KU Leuven

Alejandro Frangi
Co-chair of the UK In Silico Regulatory Innovation Task Force
University of Manchester

Francesco Pappalardo
Full Professor in Computer Science
University of Catania

Pras Pathmanathan
Senior scientist
US Food and Drug Administration

Angel Guzman Rodriguez
S&C Project Engineer Advisor Standardization and Testing ASME
Angel Guzman Rodriguez is Project Engineer Advisor at ASME. He graduated from Hofstra University in …

Blanca Rodriguez
Professor of Computational Medicine and Welcome Trust Senior Research Fellow
University of Oxford

Claudio Capelli
Research Associate
University College London (UCL)

Jérôme Noailly
Chair of the Artificial Intelligence Task Force
Universitat Pompeu Fabra

Klaus Zeier
Team Manager Health DIN - German Institute for Standardization
Klaus Zeier has a more than 10 years carreer at DIN, the German Institute for Standardization. …

Mark Palmer
Senior Chief Technologist for Healthcare
Ansys

Michael Kipping
Health Innovation Lead at Innovate UK
Michael Kipping is a Health Innovation Lead at Innovate UK and responsible for the Biomedical …

Raj Madabushi
Associate Director, Guidance and Scientific Policy, Office of Clinical Pharmacology
OTS / CDER / FDA

Randall L Schiestl
Vice President, R&D Global Technology & Services Boston Scientific Corporation
Randall L. Schiestl, PMP, is Vice President, R&D, Global Technology & Services at Boston Scientific …

Walter Schmidt
Managing Chief Engineer - Stryker
Walter Schmidt is a managing Chief Engineer in Stryker’s Joint Replacement Division, where he has …